33363455|t|Fyn-tau Ablation Modifies PTZ-Induced Seizures and Post-seizure Hallmarks of Early Epileptogenesis.
33363455|a|Both Fyn and tau have been associated with neuronal hyperexcitability and neurotoxicity in many tauopathies, including Alzheimer's disease (AD). Individual genetic ablation of fyn or tau appears to be protective against aberrant excitatory neuronal activities in AD and epilepsy models. It is, however, still unknown whether ablation of both Fyn and tau can likely elicit more profound anti-seizure and neuroprotective effects. Here, we show the effects of genetic deletion of Fyn and/or tau on seizure severity in response to pentylenetetrazole (PTZ)-induced seizure in mouse models and neurobiological changes 24 h post-seizures. We used Fyn KO (fyn -/-), tau KO (tau -/-), double knockout (DKO) (fyn -/- / tau -/-), and wild-type (WT) mice of the same genetic background. Both tau KO and DKO showed a significant increase in latency to convulsive seizures and significantly decreased the severity of seizures post-PTZ. Although Fyn KO did not differ significantly from WT, in response to PTZ, Fyn KO still had 36 +- 8% seizure reduction and a 30% increase in seizure latency compared to WT. Surprisingly, in contrast to WT, Fyn KO mice showed higher mortality in <20 min of seizure induction; these mice had severe hydrocephalous. None of the tau -/- and DKO died during the study. In response to PTZ, all KO groups showed a significant reduction in neurodegeneration and gliosis, in contrast to WT, which showed increased neurodegeneration [especially, parvalbumin (PV)-GABAergic interneurons] and gliosis. DKO mice had the most reduced gliosis. Immunohistochemically, phospho-tau (AT8, pS199/S202), Fyn expression, as well as Fyn-tau interaction as measured by PLA increased in WT post-PTZ. Moreover, hippocampal Western blots revealed increased levels of AT8, tyrosine phospho-tau (pY18), and phosphorylated Src tyrosine family kinases (pSFK) in PTZ-treated WT, but not in KO, compared to respective controls. Furthermore, PV interneurons were protected from PTZ-induced seizure effects in all KO mice. The levels of inwardly rectifying potassium (Kir 4.1) channels were also downregulated in astrocytes in the WT post-PTZ, while its levels did not change in KO groups. Overall, our results demonstrated the role of Fyn and tau in seizures and their impact on the mediators of early epileptogenesis in PTZ model.
33363455	0	3	Fyn	Gene	14360
33363455	26	29	PTZ	Chemical	MESH:D010433
33363455	38	46	Seizures	Disease	MESH:D012640
33363455	56	63	seizure	Disease	MESH:D012640
33363455	83	98	Epileptogenesis	Disease	
33363455	105	108	Fyn	Gene	14360
33363455	143	169	neuronal hyperexcitability	Disease	MESH:D009410
33363455	174	187	neurotoxicity	Disease	MESH:D020258
33363455	196	207	tauopathies	Disease	MESH:D024801
33363455	219	238	Alzheimer's disease	Disease	MESH:D000544
33363455	240	242	AD	Disease	MESH:D000544
33363455	276	279	fyn	Gene	14360
33363455	363	365	AD	Disease	MESH:D000544
33363455	370	378	epilepsy	Disease	MESH:D004827
33363455	442	445	Fyn	Gene	14360
33363455	491	498	seizure	Disease	MESH:D012640
33363455	577	580	Fyn	Gene	14360
33363455	595	602	seizure	Disease	MESH:D012640
33363455	627	645	pentylenetetrazole	Chemical	MESH:D010433
33363455	647	650	PTZ	Chemical	MESH:D010433
33363455	660	667	seizure	Disease	MESH:D012640
33363455	671	676	mouse	Species	10090
33363455	722	730	seizures	Disease	MESH:D012640
33363455	740	743	Fyn	Gene	14360
33363455	748	751	fyn	Gene	14360
33363455	799	802	fyn	Gene	14360
33363455	838	842	mice	Species	10090
33363455	939	958	convulsive seizures	Disease	MESH:D012640
33363455	1003	1011	seizures	Disease	MESH:D012640
33363455	1017	1020	PTZ	Chemical	MESH:D010433
33363455	1031	1034	Fyn	Gene	14360
33363455	1091	1094	PTZ	Chemical	MESH:D010433
33363455	1096	1099	Fyn	Gene	14360
33363455	1122	1129	seizure	Disease	MESH:D012640
33363455	1162	1169	seizure	Disease	MESH:D012640
33363455	1227	1230	Fyn	Gene	14360
33363455	1234	1238	mice	Species	10090
33363455	1277	1284	seizure	Disease	MESH:D012640
33363455	1302	1306	mice	Species	10090
33363455	1318	1332	hydrocephalous	Disease	
33363455	1400	1403	PTZ	Chemical	MESH:D010433
33363455	1453	1470	neurodegeneration	Disease	MESH:D019636
33363455	1475	1482	gliosis	Disease	MESH:D005911
33363455	1526	1543	neurodegeneration	Disease	MESH:D019636
33363455	1557	1568	parvalbumin	Gene	19293
33363455	1570	1572	PV	Gene	19293
33363455	1602	1609	gliosis	Disease	MESH:D005911
33363455	1615	1619	mice	Species	10090
33363455	1641	1648	gliosis	Disease	MESH:D005911
33363455	1704	1707	Fyn	Gene	14360
33363455	1731	1734	Fyn	Gene	14360
33363455	1791	1794	PTZ	Chemical	MESH:D010433
33363455	1952	1955	PTZ	Chemical	MESH:D010433
33363455	2029	2031	PV	Gene	19293
33363455	2065	2068	PTZ	Chemical	MESH:D010433
33363455	2077	2084	seizure	Disease	MESH:D012640
33363455	2103	2107	mice	Species	10090
33363455	2154	2161	Kir 4.1	Gene	16513
33363455	2225	2228	PTZ	Chemical	MESH:D010433
33363455	2322	2325	Fyn	Gene	14360
33363455	2337	2345	seizures	Disease	MESH:D012640
33363455	2389	2404	epileptogenesis	Disease	
33363455	2408	2411	PTZ	Chemical	MESH:D010433
33363455	Association	MESH:D000544	14360
33363455	Positive_Correlation	MESH:D010433	MESH:D019636
33363455	Positive_Correlation	MESH:D010433	19293
33363455	Association	MESH:D024801	14360
33363455	Association	MESH:D012640	14360
33363455	Association	MESH:D020258	14360
33363455	Positive_Correlation	MESH:D010433	MESH:D005911
33363455	Positive_Correlation	MESH:D010433	MESH:D012640
33363455	Association	14360	16513
33363455	Association	MESH:D009410	14360

